Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized masked controlled study of suprachoroidal CLS-TA for uveitic macular edema
MOH_2017-06-21_000544Phase 3Completed
- Sponsor
- Clearside Biomedical
- Start
- Jun 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triamcinolone in macular edema (2 arms), sponsored by Clearside Biomedical. Started Jun 2016; status: completed.
02
Drugs
triamcinolone
03
Conditions
macular edema
Beyond the preview
Go deeper on MOH_2017-06-21_000544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-06-21_000544.